CORZQ — Core Scientific Balance Sheet
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeSmall CapNeutral
- $110.89m
- $1.13bn
- $544.48m
Annual balance sheet for Core Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | 6.66 | 8.67 | 118 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 0.177 | 1.11 | 1.68 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 11.1 | 70.9 | 757 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 81.3 | 85.2 | 597 |
| Net Goodwill | |||
| Net Intangible Assets | |||
| Other Long Term Assets | |||
| Total Assets | 162 | 226 | 2,439 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 19.5 | 69.6 | 320 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 26.2 | 91.9 | 1,053 |
| Redeemable Preferred Stock | |||
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | 136 | 134 | 1,386 |
| Total Liabilities & Shareholders' Equity | 162 | 226 | 2,439 |
| Total Common Shares Outstanding |